Kineta has been granted a patent for compounds with specific structures for treating conditions related to proteostasis dysfunction. The invention includes compositions and treatment methods. GlobalData’s report on Kineta gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Kineta, Peptide pharmacophores was a key innovation area identified from patents. Kineta's grant share as of May 2024 was 20%. Grant share is based on the ratio of number of grants to total number of patents.
The granted patent (Publication Number: US11958873B2) discloses a compound with a specific chemical structure, along with its pharmaceutically acceptable forms such as salts, solvates, clathrates, or prodrugs. The compound's structure is defined by various parameters, including the presence of specific groups like C(Ra), hydrogen, methyl, CH, N, and others. Additionally, the compound's composition includes elements like R1, R2, R3c, R3f, Z, and more, each contributing to its pharmacological properties and potential applications.
Furthermore, the patent encompasses the use of the disclosed compound in pharmaceutical compositions for treating conditions related to proteostasis dysfunction and alleviating cancer symptoms in various types such as breast, colon, pancreatic, prostate, lung, ovarian, and others. The methods described involve administering the compound or its derivatives in effective amounts to patients in need of such treatments. The patent's detailed claims provide a comprehensive overview of the compound's structure, variations, and potential therapeutic applications, highlighting its significance in the field of pharmaceutical research and development.
To know more about GlobalData’s detailed insights on Kineta, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
